41 / 56
41
ES-08
Educational Seminar
16:30–17:30
East Meetingroom 13
Optimizingmedicationmanagement of adult ADHD
Chairs: P. Mattos, Brazil, C.B. Surman, USA
Description
Pharmacological treatment for adult ADHD must take
into consideration several aspects related both to the
pharmacological properties of available medications and
clinical aspects of the disorder itself. Psychostimulants
differ on their pharmacodynamic and phamarcokinetic
profiles and may be associated with a myriad of size
effects. In addition, not all ADHD symptoms present the
same degree of response to medication. Clinical aspects
which may influence the choice of medication include
psychiatric and clinical comorbidities.
ME-04
Meet-the-Expert-Session
16:30–17:30
East Meetingroom 11/12
The assessment and treatment of anger, irritability,
aggression and oppositional defiant disorder in
ADHD in the real clinical setting
Chair: D. Quinn, Canada
Description
ODD has become a renewed focus of research and there
has been a sub-classification of ODD in the DSM-5 in 2015
to three potential subtypes, Irritable, Headstrong and
Vindictive. The sub-classification of ODD is questionable.
The clinical presentation of ODD can be confused with
disruptive mood dysregulation disorder (DMDD) and
intermittent explosive disorder (IED) and bipolar disorder.
This seminar will cover these issues, and discuss whether
ODD is inherently a disorder of irritability and should
perhaps be renamed a disorder of emotional regulation.
The impact of ODD in the clinical outcome of ADHD has
been under recognized and poorly understood and will
be reviewed.
ME-05
Meet-the-Expert-Session
16:30–17:30
East Meetingroom 8/15
Assessment and treatment of ADHD in old age
Chair: S. Kooij, The Netherlands
Description
In this session, all questions about the prevalence, clinical
picture, assessment and experiences with treatment of
ADHD in old age (>65 years of age) will be interactively
discussed with the audience. As older people are in another
societal position after retirement, their treatment wishes
may be different from those of younger adults with ADHD.
New data on their treatment wishes will be presented, that
may be regarded as a guideline for the development of
tailored treatment of ADHD in this age group.
ME-06
Meet-the-Expert-Session
16:30–17:30
East Meetingroom 9
Evidence-based assessment and interventions in
ADHD and learning disorders
Chair: R. Tannock, Canada
Description
ADHD and SLD co-occur frequently at a higher rate than
expected by chance: Estimates suggest that as many as
40% of youngsters with ADHD will also meet diagnostic
criteria for SLD. Moreover, ADHD per se, is associated
with low academic achievement, even in the absence
of co-existing SLD. Both ADHD and SLD, alone and in
combination, often persist into adulthood, giving rise
to substantive impairment in academic, occupational,
and social functioning. However, assessment and
intervention for this common neurodevelopmental
complex condition is challenging – in part because the
component disorders are typically assessed and treated
by separate professionals and organization, without
adequate coordination or communication. Whereas
ADHD is generally diagnosed and treated by healthcare
professionals (e.g., physicians, clinical psychologists), SLD
is typically identified andmanaged by professionals within
the education system (educators, school psychologists).
Moreover, healthcare and educational professional may
hold different conceptualizations of ADHD and SLD,
which will influence their approach to assessment and
management. In this session, we will first discuss the
difference between ‘diagnosis' and ‘identification' and
their implications for treatment/management. Then we
will review what constitutes evidence-based assessment
for coexisting ADHD and SLD as well as pharmacological,
psychosocial, educational interventions for this complex
condition, focusing primarily on school-aged youngsters,
but also extending to older adolescents and adults. We
will conclude with an open discussion of issues, using
case studies.
Educational Seminars
Saturday, 22 April 2017